A direct effect of IFN-γ signaling on tumor and stromal cells is to upregulate the ligands PD-L1 and PD-L2, which bind with PD-1 on tumor-infiltrating T cells, thus suppressing the cytotoxic response. The gene discussed is PDCD1LG2; the disease is neoplasm.